Biochemical heterogeneity of mesenchymal stem cell populations: Clues to their therapeutic efficacy

Cell Cycle

Volumn 6, Issue 23, 2007, Pages 2884-2889

  Phinney, Donald G ^a  

^a TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Marrow stromal cells; Mesenchymal multipotent stromal cells; Mesenchymal stem cells; Serial analysis of gene expression

Indexed keywords

ANGIOGENIC FACTOR; INTERLEUKIN 1; REGULATOR PROTEIN;

ANGIOGENESIS; BONE MARROW CELL; CELL DIFFERENTIATION; CELL LINEAGE; CELL SUBPOPULATION; CELL THERAPY; HEMATOPOIESIS; HOMEOSTASIS; HUMAN; IMMUNITY; MESENCHYMAL STEM CELL; MICROENVIRONMENT; MULTIPOTENT STEM CELL; NONHUMAN; REVIEW; SERIAL ANALYSIS OF GENE EXPRESSION; STROMA CELL; TISSUE REPAIR;

ANIMALIA;

EID: 37549053263     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.6.23.5095     Document Type: Review

References (73)

1. Phinney DG. Building a consensus regarding the nature and origin of mesenchymal stem cells. J Cell Biochem 2002; S38:7-12.
2. Phinney DG. Gene expression profiles of mesenchymal stem cells. In: Nolta JA, ed. Genetic Engineering of Mesenchymal Stem Cells. Chapter 3. The Netherlands: Springer, P.O. Box 17, 3300 AA Dordrecht, 2006:59-80.
3. Dennis JE, Merriam A, Awadallah A, Yoo JU, Johnstone B, Caplan AI. A quadri-potential mesenchymal progenitor cell isolated from the marrow of an adult mouse. J Bone Miner Res 1999; 14:700-9.
4. Pittenger MF, MacKay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284:143-7.
5. Kuznetsov SA, Krebsbach PH, Satomura K, Kerr J, Riminucci M, Benayahu D, Robey PG. Single-colony derived strains of human marrow stromal fibroblasts form bone after transplantation in vivo. J Bone Miner Res 1997; 12:1335-47.
6. Caplan AI. The mesengenic process. Clinics in Plastic Surgery 1994; 21:429-5.
7. Koc ON, Gerson SL, Cooper BW, Dyhouse SM, Haynesworth SE, Caplan AI, Lazarus HM. Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy. J Clin Oncol 2000; 18:307-16.
8. Horwitz EM, Prockop DJ, Fitzpatrick LA, Koo WW, Gordon PL, Neel M, Sussman M, Orchard P, Marx JC, Pyeritz RE, Brenner MK. Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat Med 1999; 5:309-3.
9. Horwitz EM, Gordon PL, Koo WK, Marx JC, Neel MD, McNall RY, Muul L, Hofmann T. Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone. Proc Natl Acad Sci USA 2002; 99:8932-7.
10. Kopen G, Prockop DJ, Phinney DG. Marrow stromal cells migrate throughout forebrain and cerebellum, and they differentiate into astrocytes after injection into neonatal mouse brains. Proc Natl Acad Sci USA 1999; 96:10711-6.
11. Kotton DN, Ma BY, Cardoso WV, Sanderson EA, Summer RS, Williams MC, Fine A. Bone marrow-derived cells as progenitors of lung alveolar epithelium. Development 2001; 128:5181-8.
12. Ortiz LA, Gambelli F, McBride C, Gaupp D, Baddoo M, Kaminski N, Phinney DG. Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects. Proc Natl Acad Sci USA 2003; 100:8407-11.
13. Wang G, Bunnell BA, Painter RG, Quiniones BC, Tom S, Lanson Jr NA, Spees JL, Bertucci D, Peister A, Weiss DJ, Valentine VG, Prockop DJ, Kolls JK. Adult stem cells from bone marrow stroma differentiate into airway epithelial cells: Potential therapy for cystic fibrosis. Proc Natl Acad Sci USA 2005; 102:186-91.
14. Sato Y, Araki H, Kato J, Nakamura K, Kawano Y, Kobune M, Sato T, Miyanishi K, Takayama T, Takahashi M, Takimoto R, Iyama S, Matsunaga T, Ohtani S, Matsuura A, Hamada H, Niitsu Y. Human mesenchymal stem cells xenografted directly to rat liver are differentiated into human hepatocytes without fusion. Blood 2005; 106:756-63.
15. Pittenger MF, Martin BJ. Mesenchymal stem cells and their potential as cardiac therapeutics. Circ Res 2004; 95:9-20.
16. Lee RH, Seo MJ, Reger RL, Spees JL, Pulin AA, Olson SD, Prockop DJ. Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice. Proc Natl Acad Sci USA 2006; 103:17438-43.
17. Phinney DG, Isakova I. Plasticity and therapeutic potential of mesenchymal stem cells in the nervous system. Curr Pharm Design 2005; 11:1255-65.
18. Rojas M, Xu J, Woods CR, Mora AL, Spears W, Roman J, Brigham KL. Bone marrow-derived mesenchymal stem cells in repair of the injured lung. Am J Respir Cell Mol Biol 2005; 33:145-52.
19. Le Blanc K, Rasmusson I, Sundberg B, Gotherstrom C, Hassan M, Uzunel M, Ringden O. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 2004; 363:1439-41.
20. Hung SC, Pochampally RR, Chen SC, Hsu SC, Prockop DJ. Angiogenic effects of human multipotent stromal vells (MSCs): Conditioned medium activates the PI3K-Akt pathway in hypoxic endothelial cells to inhibit apoptosis, increase survival, and stimulate angiogenesis. Stem Cells 2007, (epub ahead of print).
21. Inoue Y, Iriyama A, Ueno S, Takahashi H, Kondo M, Tamaki Y, Araie M, Yanagi Y. Subretinal transplantation of bone marrow mesenchymal stem cells delays retinal degeneration in the RCS rat model of retinal degeneration. Exp Eye Res 2007; 85:234-41.
22. Togel F, Hu Z, Weiss K, Isaac J, Lange C, Westenfelder C. Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms. Am J Physiol Renal Physiol 2005; 289:F31-42.
23. Ortiz LA, Dutreil M, Fattman C, Pandey AC, Torres G, Go K, Phinney DG. Interleukin 1 receptor antagonist mediates the anti-inflammatory and anti-fibrotic effect of mesenchymal stem cells during lung injury. Proc Natl Acad Sci USA 2007; 104:11002-7.
24. Xu J, Woods CR, Mora AL, Joodi R, Brigham KL, Iyer S, Rojas M. Prevention of endotoxin-induced systemic response by bone marrow-derived mesenchymal stem cells in mice. Am J Physiol Lung Cell Mol Physiol 2007; 293:L131-41.
25. Gupta N, Su X, Popov B, Lee JW, Serikov V, Matthay MA. Intrapulmonary delivery of bone marrow-derived mesenchymal stem cells improves survival and attenuates endotoxin-induced acute lung injury in mice. J Immunol 2007; 179:1855-63.
26. Guo J, Lin GS, Bao CY, Hu ZM, Hu MY. Anti-Inflammation role for mesenchymal stem cell transplantation in myocardial infarction. Inflammation 2007; 30:97-104.
27. Ucelli A, Pistoia V, Moretta L. Mesenchymal stem cells: A new strategy for immunosuppression? Trends Immunol 2007; 28:219-26.
28. Munoz JR, Stoutenger BR, Robinson AP, Spees JL, Prockop DJ. Human stem/progenitor cells from bone marrow promote neurogenesis of endogenous neural stem cells in the hippocampus of mice. Proc Natl Acad Sci USA 2005; 102:18171-6.
29. Faubert A, Lessard J, Sauvagear G. Are genetic determinants of asymmetric cell division active in hematopoietic stem cells? Oncogene 2004; 23:7247-55.
30. Cayouette M, Raff M. Asymmetric segregation of Numb: A mechanism for neural specification from Drosophila to mammals. Nat Neurosci 2002; 5:1265-9.
31. Knoblich JA. Asymmetric cell division during animal development. Nat Rev Mol Cell Biol 2001; 2:11-20.
32. Wright WE, Shay JW. Historical claims and current interpretations of replicative aging. Nature Biotech 2002; 20:682-8.
33. Kaur P. Interfollicular epidermal stem cells: Identification, challenges, potential. J Invest Dermatol 2006; 126:1450-8.
34. Theise ND. The stem cell niche and tissue biology. Stem Cell Rev 2006; 2:169-70.
35. Horwitz EM, Le Blanc K, Dominici M, Mueller I, Slaper-Cortenbach I, Marini FC, Deans RJ, Krause DS, Keating A. The international society for cellular therapy. Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement. Cytotherapy 2005; 7:393-5.
36. Phinney DG, Righter W, Kopen G, Webster S, Tremain N, Prockop DJ. Donor variation in the growth properties and osteogenic potential of human marrow stromal cells. J Cell Biochem 1999; 75:424-36.
37. DiGirolamo CM, Stokes D, Colter D, Phinney DG, Prockop DJ. Propagation and senescence of human marrow stromal cells in culture: A simple colony-forming assay identifies samples with the greatest potential to propagate and differentiate. Br J Hematol 1999; 107:275-81.
38. Muraglia A, Cancedda R, Quarto R. Clonal mesenchymal progenitors from human bone marrow differentiate in vitro according to a hierarchical model. J Cell Sci 2000; 113:1161-6.
39. Bianco P, Robey PG. Marrow stromal stem cells. J Clin Invest 2000; 105:1663-8.
40. Sudo K, Kanno M, Miharada K, Ogawa S, Hiroyama T, Saijo K, Nakamura Y. Mesenchymal progenitors able to differentiate into osteogenic, chondrogenic, and/or adipogenic cells in vitro are present in most primary fibroblast-like cell populations. Stem Cells 2007; 25:1610-7.
41. Hong JH, Yaffe MB. TAZ: A b-catenin-like molecule that regulates mesenchymal stem cell differentiation. Cell Cycle 2006; 5:176-9.
42. Tremain N, Korrko J, Kopen GC, Ibberson D, DiGirolamo C, Phinney DG. MicroSAGE analysis of 2353 expressed genes in a single cell-derived colony of undifferentiated human mesenchymal stem cells reveal mRNAs of multiple cell lineages. Stem Cells 2001; 19:408-18.
43. Phinney DG, Hill K, Michelson C, DuTreil M, Hughes C, Humphries S, Wilkinson R, Baddoo M, Bayly E. Biological activities encoded by the murine mesenchymal stem cell transcriptome provide a basis for their developmental plasticity and broad clinical efficacy. Stem Cells 2006; 24:186-98.
44. Crigler L, Robey RC, Asawachaicharn A, Gaupp D, Phinney DG. Human mesenchymal stem cells express a variety of neuro-regulatory molecules and promote neuronal cell survival and neuritogenesis. Exp Neurol 2006; 198:54-64.
45. Phan SH, Kunkel SL. Lung cytokine production in bleomycin-induced pulmonary fibrosis. Exp Lung Res 1992; 18:29-43.
46. Cavarra E, Carraro F, Fineschi S, Naldini A, Bartalesi B, Pucci A, Lungarella G. Early response to bleomycin is characterized by different cytokine and cytokine receptor profiles in lungs. Am J Physiol Lung Cell Mol Physiol 2004; 287:L1186- 92.
47. Phinney DG, Baddoo M, Dutreil M, Gaupp D, Lai WT, Isakova IA. Murine mesenchymal stem cells transplanted to the central nervous system of neonatal versus adult mice exhibit distinct engraftment kinetics and express receptors that guide neuronal cell migration. Stem Cells Dev 2006; 15:437-47.
48. Isakova IA, Baker K, Dufour J, Gaupp D, Phinney DG. Preclinical evaluation of adult stem cell engraftment and toxicity in the CNS of rhesus macaques. Mol Ther 2006; 13:1173-84.
49. Zimmet JM, Hare JM. Emerging role for bone marrow derived mesenchymal stem cells in myocardial regenerative therapy. Basic Res Cardiol 2005; 100:471-81.
50. Tang YL, Zhao Q, Qin X, Shen L, Cheng L, Ge J, Phillips MI. Paracrine action enhances the effects of autologous mesenchymal stem cell transplantation on vascular regeneration in rat model of myocardial infarction. Ann Thorac Surg 2005; 80:229-36, (discussion 236-7).
51. Zhu W, Xu W, Jiang R, Qian H, Chen M, Hu J, Cao W, Han C, Chen Y. Mesenchymal stem cells derived from bone marrow favor tumor cell growth in vivo. Exp Mol Pathol 2006; 80:267-74.
52. Wu XZ, Chen D, Xie GR. Bone marrow-derived cells: Roles in solid tumor. Minireview Neoplasma 2007; 54:1-6.
53. Orimo A, Weinberg RA. Stormal fibroblasts in cancer: A novel tumor-promoting cell type. Cell Cycle 2006; 5:1597-601.
54. Weiss L. The hematopoietic microenvironment of bone marrow: An ultra structural study of the stroma in rats. Anat Rec 1976; 186:161-84.
55. Yamazaki K, Allen TD. Ultra structural morphometric study of efferent nerve terminals on murine bone marrow stromal cells, and the recognition of a novel anatomical unit: The "neuro-reticular complex". Am J Anat 1990; 187:261-76.
56. Lemer UH. Neuropeptidergic regulation of bone resorption and bone formation. J Musculoskelet Neuronal Interact 2002; 2:440-7.
57. Fu L, Patel MS, Bradley A, Wagner EF, Karsenty G. The molecular clock mediates eptin-regulated bone formation. Cell 2005; 122:803-15.
58. Matsuda H, Coughlin MD, Bienestock J, Denburg JA. Nerve growth factor promotes human hematopoietic colony growth and differentiation. Proc Natl Acad Sci USA 1988; 85:6508-12.
59. Simone MD, De Santis S, Vigneti E, Papa G, Amadori S, Aloe L. Nerve growth factor: A survey of activity on immune and hematopoietic cells. Hematol Oncol 1999; 17:1-10.
60. Schuhmann B, Dietrich A, Sel S, Hahn C, Klingenspor M, Lommatzsch M, Gudermann T, Braun A, Renz H, Nockher WA. A role for brain-derived neurotrophic factor in B cell development. J Neuroimmunol 2005; 163:15-23.
61. Hattori K, Dias S, Heissig B, et al. Vascular endothelial growth factor and angiopoietin-1 stimulate postnatal hematopoiesis by recruitment of vasculogenic and hematopoietic stem cells. J Exp Med 2001; 193:1005-14.
62. Wei S, Kitaura H, Zhou P, Ross FP, Teitelbaum SL. IL-1 mediates TNF-induced osteoclastogenesis. J Clin Invest 2005; 115:282-90.
63. Koshy PJ, Londy CJ, Rowan AD, Porter S, Edwards DR, Hogan A, Clark IM, Cawston TE. The modulation of matrix metalloproteinase and ADAM gene expression in human chondrocytes by interleukin-1 and oncostatin M: A time-course study using real-time quantitative reverse transcription-polymerase chain reaction. Arthritis Rheum 2002; 46:961-7.
64. Strand V, Kavanaugh AF. The role of interleukin-1 in bone resorption in rheumatoid arthritis. Rheumatology (Oxford) 2004; 43(Suppl 3):iii10-6.
65. Abramson SB, Amin A. Blocking the effects of IL-1 in rheumatoid arthritis protects bone and cartilage. Rheumatology (Oxford) 2002; 41:972-80.
66. Cheng SL, Shin CS, Towler DA, Civitelli R. A dominant negative cadherin inhibits osteoblast differentiation. J Bone Miner Res 2000; 15:2362-70.
67. Zhang J, Niu C, Ye L, Huang H, He X, Tong WG, Ross J, Haug J, Johnson T, Feng JQ, Harris S, Wiedemann LM, Mishina Y, Li L. Identification of the hematopoietic stem cell niche and control of the niche size. Nature 2003; 425:836-41.
68. Wu JY, Feng L, Park HT, Havlioglu N, Wen L, Tang H, Bacon KB, Jiang ZH, Zhang XC, Rao. The neuronal repellent Slit inhibits leukocyte chemotaxis induced by chemotactic factors. Nature 2001; 410:948-52.
69. Vargesson N, Luria V, Erskine L, Laufer E. Expression patterns of Slit and Robo family members during vertebrate limb development. Mech Dev 2001; 106:175-80.
70. Huminiecki L, Gorn M, Suchting S, Poulsom R, Bicknell R. Magic roundabout is a new member of the roundabout receptor family that is endothelial specific and expressed at sites of active angiogenesis. Genomics 2002; 79:547-52.
71. Neufeld G, Kessler O, Herzog Y. The interaction of Neuropilin-1 and Neuropilin-2 with tyrosine-kinase receptors for VEGF. Adv Exp Med Biol 2002; 515:81-90.
72. Yuan L, Moyon D, Pardanaud L, Breant C, Karkkainen MJ, Alitalo K, Eichmann A. Abnormal lymphatic vessel development in neuropilin 2 mutant mice. Development 2002; 129:4797-806.
73. Baddoo M, Hill K, Wilkinson R, Gaupp D, Hughes C, Kopen GC, Phinney DG. Characterization of mesenchymal stem cells isolated from murine bone marrow by negative selection. J Cell Biochem 2003; 89:1235-49.